000 01615 a2200457 4500
005 20250513121340.0
264 0 _c19970701
008 199707s 0 0 eng d
022 _a0041-1132
024 7 _a10.1046/j.1537-2995.1997.37697335156.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeckers, E A
245 0 0 _aLower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene.
_h[electronic resource]
260 _bTransfusion
_cJun 1997
300 _a616-23 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAutoradiography
650 0 4 _aBlotting, Southern
650 0 4 _aCoombs Test
650 0 4 _aDNA, Complementary
_xblood
650 0 4 _aErythrocytes
_xchemistry
650 0 4 _aFlow Cytometry
_xmethods
650 0 4 _aGene Expression Regulation
650 0 4 _aGlycoproteins
_xblood
650 0 4 _aHemagglutination Tests
650 0 4 _aHumans
650 0 4 _aIsoantigens
_ximmunology
650 0 4 _aPhenotype
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aRNA, Messenger
_xanalysis
650 0 4 _aRh-Hr Blood-Group System
_xgenetics
700 1 _aFaas, B H
700 1 _aLigthart, P
700 1 _aOverbeeke, M A
700 1 _avon dem Borne, A E
700 1 _avan der Schoot, C E
700 1 _avan Rhenen, D J
773 0 _tTransfusion
_gvol. 37
_gno. 6
_gp. 616-23
856 4 0 _uhttps://doi.org/10.1046/j.1537-2995.1997.37697335156.x
_zAvailable from publisher's website
999 _c9172449
_d9172449